GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Mar SA (LTS:0RC6) » Definitions » Purchase Of Investment

Pharma Mar (LTS:0RC6) Purchase Of Investment : €-351.5 Mil (TTM As of Dec. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Pharma Mar Purchase Of Investment?

Pharma Mar's purchase of investment for the three months ended in Dec. 2024 was €-90.4 Mil. It means Pharma Mar spent €90.4 Mil on purchasing investments. Pharma Mar's purchase of investment for the trailing twelve months (TTM) ended in Dec. 2024 was €-351.5 Mil.

Compared with last quarter (€-67.1 Mil in Sep. 2024 ), Pharma Mar spent more money on purchasing investments in Dec. 2024 (€-90.4 Mil).

Pharma Mar Purchase Of Investment Historical Data

The historical data trend for Pharma Mar's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharma Mar Purchase Of Investment Chart

Pharma Mar Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Purchase Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only -116.01 - -219.20 -314.33 -351.48

Pharma Mar Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Purchase Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.65 -92.04 -101.94 -67.05 -90.44

Pharma Mar Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-351.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pharma Mar Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Pharma Mar's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharma Mar Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharma Mar SA (LTS:0RC6) » Definitions » Purchase Of Investment
Comparable Companies
XMAD:ATRY XMAD:ORY XMAD:BST XMAD:VYT VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX SMMT INSM HKSE:02269 BMRN RPRX XKRX:196170
Traded in Other Exchanges
PHMMF:USA PHMe:UK PHM:Spain PMRA:Germany PMRA:Germany PHM:Austria
Address
Avenida de los Reyes, 1, Poligono Industrial La Mina-norte, Colmenar Viejo, Madrid, ESP, 28770
Website
http://www.pharmamar.com
Pharma Mar SA is engaged in the research, development, production, and commercialization of bio-active principles of marine origin for application in oncology. It also produces and markets insecticides and air fresheners for household use, household products, wood treatment and decoration products, paints, and similar products. Its operating business segments are Oncology and RNAi. The company obtains its revenues from two main areas: biopharmaceuticals and consumer chemicals, but the biopharmaceuticals is the main line of business.

Pharma Mar Headlines

No Headlines